Oxford coronavirus vaccine breakthrough in 'adults over 60' – strong immune response

A CORONAVIRUS vaccine candidate developed by AstraZeneca Plc and Oxford University produced a strong immune response in older adults, offering hope it may protect some of those deemed most vulnerable, data has shown.

Oxford coronavirus vaccine breakthrough in 'adults over 60' – strong immune response


A CORONAVIRUS vaccine candidate developed by AstraZeneca Plc and Oxford University produced a strong immune response in older adults, offering hope it may protect some of those deemed most vulnerable, data has shown.